YAVNE, Israel, July 16, 2019-- MediWound Ltd., a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in.
MediWound to Host Analyst Day on its Innovative Product EscharEx® for Debridement of Chronic Wounds - Nasdaq
Read More
No comments:
Post a Comment